Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$45,322,377
-$28,594,426 QoQ
Shares Held
180,108
-47.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#394
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LORD, ABBETT & CO. LLC holds $1,248,570,920 across 7 Drug Manufacturers - General names. ABBV ranks #5 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
427,913 | $513,251,732 | |
| 2 | JNJ |
Johnson & Johnson
|
1,477,212 | $375,167,531 | |
| 3 | NVS |
Novartis AG
|
1,002,335 | $157,085,941 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
929,682 | $117,456,023 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
180,108 | $45,322,377 | |
| 6 | BIIB |
Biogen Inc.
|
130,184 | $28,127,555 | |
| 7 | AZN |
Astrazeneca PLC
|
64,127 | $12,159,761 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,322,377 | 180,108 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $73,916,803 | 339,863 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $237,310,399 | 1,038,603 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $266,357,595 | 1,150,374 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $210,027,545 | 1,131,492 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $267,334,529 | 1,275,938 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $228,063,911 | 1,283,421 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $322,828,256 | 1,634,739 | Shares | Other | 2024-12-13 | |
| 2024-06-30 | $304,828,945 | 1,777,221 | Shares | Other | 2024-10-07 | |
| 2024-03-31 | $318,895,158 | 1,751,209 | Shares | Other | 2024-10-07 | |
| 2023-12-31 | $275,285,608 | 1,776,380 | Shares | Other | 2024-10-07 | |
| 2023-09-30 | $295,190,672 | 1,980,348 | Shares | Sole | 2024-10-07 | |
| 2023-06-30 | $279,266,592 | 2,072,787 | Shares | Sole | 2024-10-07 | |
| 2023-03-31 | $330,135,114 | 2,071,501 | Shares | Sole | 2024-10-07 | |
| 2022-12-31 | $344,277,136 | 2,130,296 | Shares | Sole | 2024-10-07 | |
| 2022-09-30 | $291,739,255 | 2,173,752 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $344,014,207 | 2,246,110 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $439,793,406 | 2,712,932 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $365,521,371 | 2,699,567 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $271,922,255 | 2,520,833 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $221,942,927 | 1,970,374 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $227,975,602 | 2,106,594 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $217,510,535 | 2,029,963 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $162,305,496 | 1,853,014 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $150,290,506 | 1,530,765 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $91,680,569 | 1,203,315 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||